HBI Deals+Insights / Internationalisation
Europe’s healthcare providers are less directly exposed to Donald Trump’s trade war than its med tech sector. But hospital and outpatient groups will still suffer. The severity of the pain will depend largely on the EU’s response to US tariffs, in particular the level and extent of possible counter tariffs. The EU could also be galvanised into better supporting innovation and R&D in its med tech and pharma sectors.





